Pinzon, Lilliam M.
Velazquez, Alan
Rutkoski, Holdunn
Tay, Djin L.
Martel, Lara
Drury, Carmen
Ayres, Shauna
Dixon, Barbara
Winkler, James R.
Kepka, Deanna
Article History
Received: 13 April 2021
Accepted: 28 February 2022
First Online: 14 March 2022
Declarations
:
: The present study was approved by the University of Utah’s and Institutional Review Board (IRB) (IRB_00087209) and conducted in accordance with IRB guidelines and the Declaration of Helsinki. During the required research study introductory oral presentation, a research team member stated that participant consent was assumed by the voluntary and anonymous completion and return of a survey to the research team. Participants were 18–29 years old and gave informed consent by voluntarily completing the survey.
: Not applicable.
: Dr. Kepka receives a small portion of her salary from a grant that is provided and supported by the American Cancer Society, who received funding from Merck, for the purpose of the “Mission: HPV Cancer Free Quality Improvement Initiative”. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.